Morning Overview on MSN
A cell therapy for an aggressive childhood leukemia just won breakthrough status
Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.
Acclaimed actor Sam Neill, famous for his Jurassic Park role, has passed away. His family confirmed his death on Monday, July ...
CAR T-cell therapy, a revolutionary cancer treatment known as the living drug, has shown remarkable success in combating ...
How could relapse in leukemia after CAR T treatment—a problem that still affects between 30–60% of patients—be prevented? One major driver is antigen escape: leukemia cells can dial down or lose the ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
Soficabtagene geleucel (WU-CART-007) received FDA Breakthrough Therapy Designation for treating relapsed or refractory T-cell leukemia and lymphoma. The CRISPR-engineered treatment achieved a 91% ...
An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects. In an onsite interview with CURE at the 2025 ASH ...
Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using ...
Strategies for using measurable residual disease to guide treatment decisions around the time of transplant in acute leukemia, featured in an education session and Hematology publication. Real-world ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...
Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results